<DOC>
	<DOC>NCT01210339</DOC>
	<brief_summary>The primary purpose of this study is to assess whether esomeprazole 20 mg/Acetyl Salicylic Acid (ASA) 81 mg affect the metabolism of clopidogrel.</brief_summary>
	<brief_title>An Interaction Study to Evaluate the Effect of Esomeprazole/Acetylsalicylic Acid on the Metabolism and Effect of Clopidogrel</brief_title>
	<detailed_description />
	<mesh_term>Clopidogrel</mesh_term>
	<mesh_term>Ticlopidine</mesh_term>
	<mesh_term>Aspirin</mesh_term>
	<mesh_term>Esomeprazole</mesh_term>
	<criteria>Male (aged between 18 and 45 years inclusive) or female (aged between 18 and 55 years inclusive) healthy volunteers Female healthy volunteers must be of nonchildbearing potential or be of childbearing potential, be nonlactating and have a negative pregnancy test during the preentry visit and be using 1 clinically accepted method of contraception Have a body mass index between 19 and 30 kg/m2 inclusive No clinically significant abnormal findings at the physical examination as judged by the investigator Any clinically significant abnormalities in laboratory screening results as judged by investigator Platelet count &lt;150 x 10^9/L on Day 1 or any other conditions that would increase the risk of bleeding Previous bone marrow transplant Any clinically important abnormalities in rhythm, conduction or morphology of resting ECG</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>October 2011</verification_date>
	<keyword>phase 1</keyword>
	<keyword>cross-over</keyword>
	<keyword>drug-drug Interaction</keyword>
	<keyword>esomeprazole</keyword>
	<keyword>acetylsalicylic acid</keyword>
	<keyword>clopidogrel</keyword>
	<keyword>healthy volunteers</keyword>
	<keyword>cardiovascular disease</keyword>
	<keyword>patients with acid associated gastrointestinal symptoms</keyword>
</DOC>